ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THEREOF
    2.
    发明申请
    ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THEREOF 有权
    抗病毒化合物及其制备和使用方法

    公开(公告)号:US20110212975A1

    公开(公告)日:2011-09-01

    申请号:US12850806

    申请日:2010-08-05

    CPC分类号: C07D413/06 A61K31/496

    摘要: Compounds which exhibit antiviral activity, particularly against influenza virus, and methods of making and using thereof are described herein. In one embodiment, the compounds are heterocyclic amides containing piperazine and isozazole rings and optionally substituted with one or more substituents. The compounds can be formulated with one or more pharmaceutically acceptable excipients to form compositions suitable for enteral or parenteral administration. The compounds are preferably used to treat or prevent Influenza A infections, such as H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, and H10N7.

    摘要翻译: 本文描述了显示抗病毒活性,特别是针对流感病毒的化合物及其制备和使用方法。 在一个实施方案中,化合物是含有哌嗪和异唑环并任选被一个或多个取代基取代的杂环酰胺。 可以将化合物与一种或多种药学上可接受的赋形剂配制以形成适于肠内或肠胃外给药的组合物。 该化合物优选用于治疗或预防甲型流感感染,如H1N1,H2N2,H3N2,H5N1,H7N7,H1N2,H9N2,H7N2,H7N3和H10N7。

    Antiviral compounds and methods of making and using thereof
    3.
    发明授权
    Antiviral compounds and methods of making and using thereof 有权
    抗病毒化合物及其制备和使用方法

    公开(公告)号:US09212177B2

    公开(公告)日:2015-12-15

    申请号:US12850806

    申请日:2010-08-05

    IPC分类号: A61K31/496 C07D413/06

    CPC分类号: C07D413/06 A61K31/496

    摘要: Compounds which exhibit antiviral activity, particularly against influenza virus, and methods of making and using thereof are described herein. In one embodiment, the compounds are heterocyclic amides containing piperazine and isozazole rings and optionally substituted with one or more substituents. The compounds can be formulated with one or more pharmaceutically acceptable excipients to form compositions suitable for enteral or parenteral administration. The compounds are preferably used to treat or prevent Influenza A infections, such as H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, and H10N7.

    摘要翻译: 本文描述了显示抗病毒活性,特别是针对流感病毒的化合物及其制备和使用方法。 在一个实施方案中,化合物是含有哌嗪和异唑环并任选被一个或多个取代基取代的杂环酰胺。 可以将化合物与一种或多种药学上可接受的赋形剂配制以形成适于肠内或肠胃外给药的组合物。 该化合物优选用于治疗或预防甲型流感感染,如H1N1,H2N2,H3N2,H5N1,H7N7,H1N2,H9N2,H7N2,H7N3和H10N7。